Emerging research highlights how vitamin D boosts immunity and reduces colorectal cancer (CRC) risk by regulating ...

Over 80% of patients with relapsed/refractory multiple myeloma responded to anti-GPRC5D CAR T-cell therapy after failure of anti-BCMA CAR T-cell therapy. The investigational therapy showed superior ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been ...

A compelling naturopathic case study by Dr. Eric Dorninger reveals how endotoxin exposure from kitty litter led to CIRS and ...

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been ...

A study published in the American Journal of Obstetrics & Gynecology by researchers at Baylor College of Medicine, UTHealth ...

Monitoring and analyzing gut microbes may help predict how myeloma patients will respond to CAR T-cell therapy, research ...

AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced that it will present a preclinical ...

A new implant safely triggers potent immune responses against hard-to-treat cancers showing "promise" for pancreatic and ...

Central to these processes are cytokines - soluble signaling proteins that orchestrate immune responses by mediating communication between cells. Cytokine networks exhibit dual functionality: they are ...